• Explore /
  • Poster
  • / Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC).

Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC).

Abstract Poster

Authors

null

David B. Page

Earle A. Chiles Research Institute, Portland, OR

David B. Page , Isaac K Kim , Katherine Sanchez , Nicole Moxon , Staci L. Mellinger , Alison Katherine Conlin , Anupama Kurup Acheson , Kelly Shea Perlewitz , Stacy K. Lewis , Kathleen A. Kemmer , Zahi Ibrahim Mitri , Reva K Basho , Emily Riffle , Jenny Ahn , Joanna Pucilowska , Maritza Martel , Walter John Urba , Heather L. McArthur

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

HER2-Positive

Clinical Trial Registration Number

NCT02734290

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1033)

DOI

10.1200/JCO.2018.36.15_suppl.1033

Abstract #

1033

Poster Bd #

114

Abstract Disclosures

Similar Posters

First Author: Eric P. Winer

First Author: David B. Page

First Author: Evan Justin Walker

First Author: David B. Page